Mounjaro 15 mg, solution pour injection en stylo pré-rempli

( ARTG ) Type 2 Diabetes Mellitus:,MOUNJARO is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is not tolerated or contraindicated. in addition to other medicinal products for the treatment of type 2 diabetes.,Chronic Weight Management,MOUNJARO is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management, including weight loss and weight maintenance, in adults with an initial body mass index (BMI) of: equal to or greater than 30 kg/m2 (obesity) or equal to or greater than 27 kg/m2 to less than 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes mellitus).,Obstructive Sleep Apnoea (OSA),MOUNJARO is indicated for the treatment of moderate to severe obstructive sleep apnoea in adults with obesity.